NAN and SRX share one thing in common: both were the biopharma picks in the broker/ FXJ/NWS christmas lists of broker/ adviser recommendations, other than that, both stocks are about as similar as Medibank and National Australia Bank. They might be both in the same industry sector roughly but their history, success (or failures) r fundamentally different.
Dramatic response to SIRT, page-13
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
-0.003(1.39%) |
Mkt cap ! $75.34M | |||
| Open | High | Low | Value | Volume |
| 17.8¢ | 17.8¢ | 17.5¢ | $8.638K | 48.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 11236354 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1327703 | 33 |
View Market Depth
| Last trade - 15.52pm 09/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |